Postdoc: Epigenetics of Lymphoid Development

Carrerasresearch; Badalona; Presencial; EUR 36.000 - 48.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Full-time contract (3 years)

Descripción de la vacante

The Josep Carreras Leukaemia Research Institute (IJC) invites applications for a full-time Postdoctoral Researcher in the Epigenetic Control of Haematopoiesis Group, led by Dr. José Luis Sardina, to study TET2-dependent epigenetic regulation during human lymphoid development using primary cells, hiPSC differentiation, and CRISPR approaches.

The position offers a 3-year contract in a collaborative environment with access to cutting-edge genomics and single-cell technologies in the Barcelona

Formación

• PhD in Biology, Biomedicine, Biotechnology, or related discipline.
• Strong publication record with at least one first-author paper.
• Interest in epigenetic regulation, lymphoid development, immunology, and hematological malignancies.
• Experience in computational analysis of biological datasets.
• Interest in pursuing independent funding through fellowships.
• Ability to work independently in a multidisciplinary team.
• Proficiency in English, written and spoken.

Responsabilidades

• Contribute to design, execution, and interpretation of studies on TET2 in human lymphoid development.
• Perform and develop computational analyses of epigenomic and single-cell data.
• Develop experimental and computational approaches within the project framework.
• Integrate data to investigate molecular mechanisms of lymphoid development and disease.
• Contribute to publications, conferences, and supervision of Master’s/PhD students.

Conocimientos

Epigenetic regulation

Lymphoid development

Computational data analysis

Independent funding applications

English proficiency

Educación

PhD in Biology/Biomedicine/related

Herramientas

CRISPR-based approaches

Descripción del empleo

The Josep Carreras Leukaemia Research Institute (IJC) invites applications for a full-time Postdoctoral Researcher in the Epigenetic Control of Haematopoiesis Group, led by Dr. José Luis Sardina, to study TET2-dependent epigenetic regulation during human lymphoid development using primary cells, hiPSC differentiation, and CRISPR approaches.

The position offers a 3-year contract in a collaborative environment with access to cutting-edge genomics and single-cell technologies in the Barcelona